BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31376423)

  • 1. Identification of Altered Metabolic Pathways during Disease Progression in EAE Mice via Metabolomics and Lipidomics.
    Lee G; Hasan M; Kwon OS; Jung BH
    Neuroscience; 2019 Sep; 416():74-87. PubMed ID: 31376423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.
    Singh J; Cerghet M; Poisson LM; Datta I; Labuzek K; Suhail H; Rattan R; Giri S
    J Neuroimmune Pharmacol; 2019 Jun; 14(2):241-250. PubMed ID: 30315511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
    PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple Sclerosis.
    Poisson LM; Suhail H; Singh J; Datta I; Denic A; Labuzek K; Hoda MN; Shankar A; Kumar A; Cerghet M; Elias S; Mohney RP; Rodriguez M; Rattan R; Mangalam AK; Giri S
    J Biol Chem; 2015 Dec; 290(52):30697-712. PubMed ID: 26546682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Employing metabolomic approaches to determine the influence of age on experimental autoimmune encephalomyelitis (EAE).
    Lee SH; Lee G; Seo JE; Hasan M; Kwon OS; Jung BH
    Mol Immunol; 2021 Jul; 135():84-94. PubMed ID: 33873097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in spinal cord stiffness in the course of experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.
    Pyka-Fościak G; Zemła J; Lis GJ; Litwin JA; Lekka M
    Arch Biochem Biophys; 2020 Feb; 680():108221. PubMed ID: 31816310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation.
    Mandolesi G; De Vito F; Musella A; Gentile A; Bullitta S; Fresegna D; Sepman H; Di Sanza C; Haji N; Mori F; Buttari F; Perlas E; Ciotti MT; Hornstein E; Bozzoni I; Presutti C; Centonze D
    J Neurosci; 2017 Jan; 37(3):546-561. PubMed ID: 28100738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Untargeted lipidomics based on UPLC-QTOF-MS/MS and structural characterization reveals dramatic compositional changes in serum and renal lipids in mice with glyoxylate-induced nephrolithiasis.
    Chao Y; Gao S; Wang X; Li N; Zhao H; Wen X; Lou Z; Dong X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Sep; 1095():258-266. PubMed ID: 30099286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of dasatinib in mouse model of multiple sclerosis.
    Azizi G; Goudarzvand M; Afraei S; Sedaghat R; Mirshafiey A
    Immunopharmacol Immunotoxicol; 2015 Jun; 37(3):287-94. PubMed ID: 25975582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of BDE-47 induced Parkinson's disease-like metabolic changes in C57BL/6 mice by integrated metabolomic, lipidomic and proteomic analysis.
    Ji F; Sreenivasmurthy SG; Wei J; Shao X; Luan H; Zhu L; Song J; Liu L; Li M; Cai Z
    J Hazard Mater; 2019 Oct; 378():120738. PubMed ID: 31203119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison.
    Dal Canto MC; Melvold RW; Kim BS; Miller SD
    Microsc Res Tech; 1995 Oct; 32(3):215-29. PubMed ID: 8527856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
    Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
    J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR-Based Metabolomics Separates the Distinct Stages of Disease in a Chronic Relapsing Model of Multiple Sclerosis.
    Dickens AM; Larkin JR; Davis BG; Griffin JL; Claridge TD; Sibson NR; Anthony DC
    J Neuroimmune Pharmacol; 2015 Sep; 10(3):435-44. PubMed ID: 26155956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease progression after bone marrow transplantation in a model of multiple sclerosis is associated with chronic microglial and glial progenitor response.
    Cassiani-Ingoni R; Muraro PA; Magnus T; Reichert-Scrivner S; Schmidt J; Huh J; Quandt JA; Bratincsak A; Shahar T; Eusebi F; Sherman LS; Mattson MP; Martin R; Rao MS
    J Neuropathol Exp Neurol; 2007 Jul; 66(7):637-49. PubMed ID: 17620989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of uric acid treatments on liver glutathione system prevent oxidative damages in experimental autoimmune encephalomyelitis mice.
    Allameh A; Maleklou N; Zargari M; Sanati MH
    Neurosci Lett; 2008 Jul; 439(1):111-5. PubMed ID: 18501514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Berard JL; Wolak K; Fournier S; David S
    Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilirubin as a potent antioxidant suppresses experimental autoimmune encephalomyelitis: implications for the role of oxidative stress in the development of multiple sclerosis.
    Liu Y; Zhu B; Wang X; Luo L; Li P; Paty DW; Cynader MS
    J Neuroimmunol; 2003 Jun; 139(1-2):27-35. PubMed ID: 12799017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of N-Acetylserotonin and Melatonin in the EAE Model of Multiple Sclerosis.
    Wen J; Ariyannur PS; Ribeiro R; Tanaka M; Moffett JR; Kirmani BF; Namboodiri AM; Zhang Y
    J Neuroimmune Pharmacol; 2016 Dec; 11(4):763-773. PubMed ID: 27562847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRPM2 Exacerbates Central Nervous System Inflammation in Experimental Autoimmune Encephalomyelitis by Increasing Production of CXCL2 Chemokines.
    Tsutsui M; Hirase R; Miyamura S; Nagayasu K; Nakagawa T; Mori Y; Shirakawa H; Kaneko S
    J Neurosci; 2018 Sep; 38(39):8484-8495. PubMed ID: 30201769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gelatinase B/matrix metalloproteinase-9 is a phase-specific effector molecule, independent from Fas, in experimental autoimmune encephalomyelitis.
    Ugarte-Berzal E; Berghmans N; Boon L; Martens E; Vandooren J; Cauwe B; Thijs G; Proost P; Van Damme J; Opdenakker G
    PLoS One; 2018; 13(10):e0197944. PubMed ID: 30273366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.